BAT Highlights Serious Inaccuracies in EU e-Cigarette Review
BAT has called on a European Commission scientific committee to enhance the quality of its ongoing review into e-cigarettes. BAT highlighted several serious flaws, the details of which it makes public today . The results of the review may pave the way for revisions to rules that affect millions of vapers across the EU.
The SCHEER Committee (Scientific Committee on Health, Environmental and Emerging Risks ) is an advisory body that was tasked with producing a scientific review of the health effects of e-cigarettes as part of the European Commission’s forthcoming review of the Tobacco Products Directive. The consultation period for this review has now closed.
BAT’s response highlights major flaws with the methodology and conclusions of the review including that it:
- Fails to contextualize the risks of e-cigarettes relative to those associated with continued smoking.
- Makes inaccurate claims regarding e-cigarettes many of which have been widely debunked by the scientific and public health communities.
- Contains false assumptions that e-cigarette aerosol is the same as tobacco smoke.
- Neglects landmark independent studies showing that many smokers view e-cigarettes as an acceptable alternative to smoking.
- Relies on data from non-EU markets and studies on products pre-dating the current Tobacco Products Directive that are not relevant to the current EU context.
Said Eric Sensi-Minautier, VP EU Affairs at BAT , “If future regulations on vaping were to be based on the review as it stands now, they would be based on flawed evidence. We call on the SCHEER Committee to address the serious gaps in the review and reflect the weight of evidence supporting the harm reduction potential of e-cigarettes relative to continued smoking. It’s important that the Commission bases any change to the rules on vaping on accurate scientific advice that has been conducted to the highest standards, to make sure the millions of European vapers who use e-cigarettes as an alternative to smoking can continue to access them. We take the science around e-cigarettes seriously and are leading our own weight of evidence review to advance understanding of this growing product category.”
BAT highlights the need for greater transparency and cooperation between all stakeholders including industry, government, scientists, public health bodies and academics. Click here to read BAT’s response to the public consultation.
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
PI-WORKS24.11.2020 06:02:12 CET | Press release
beCloud Selects P.I. Works to Drive Automation of its Nationwide Multi-Operator and Multi-Vendor LTE Network
CA-NEXON-AMERICA24.11.2020 04:02:11 CET | Press release
Global Superstars BTS Team Up With Iconic MapleStory Games in Brand New Collaboration
WI-SHINE-MEDICAL23.11.2020 20:02:11 CET | Press release
Von Gahlen Building Major Component of SHINE’s One-of-a-Kind Isotope Plant
CA-GRAI-MATTER-LABS23.11.2020 20:02:11 CET | Press release
GrAI Matter Labs Raises $14M to Bring Fastest AI per Watt to Every Device on the Edge
IMMERVISION23.11.2020 17:03:08 CET | Press release
Defense Innovation Unit (DIU) Selects Immervision InnovationLab to Develop a Computer Vision Wide Angle Camera for the Blue UAS Framework Project
CO-MPEG-LA-LLC23.11.2020 15:02:22 CET | Press release
Hisense Sued for Infringement of AVC Essential Patents
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom